Ушбу иш иқтибос қилган ишлар

8 та иш

Иш: Possibilities of aggressive oncosurgery in treatment of IIA–IIIB stages of cervical cancer

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram +5
Мақола20184 иқтибос
ABI
Challenges and Opportunities to Improve Cervical Cancer Screening Rates in US Health Centers through Patient-Centered Medical Home Transformation
Olga Moshkovich, Lydie A. Lebrun‐Harris, Laura Makaroff +4
Мақола20152 иқтибос
ABI
Is there a role for postoperative treatment in patients with stage Ib2–IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study
Fabio Landoni, Enrico Sartori, T Maggino +6
Мақола20132 иқтибос
ABI
Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
Jeong‐Yeol Park, Dae‐Yeon Kim, Jong-Hyeok Kim +9
Мақола20122 иқтибос
ABI
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)
Noriyuki Katsumata, Hiroyuki Yoshikawa, Hiroaki Kobayashi +12
Бошқа20132 иқтибос
ABI
Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients
Lin Gong, Jiawen Zhang, Rutie Yin +5
Мақола20162 иқтибос
ABI
Outcomes of combination therapy for stage IIA–IIIB cervical cancer
D.-K. Reyes Santiago, А. С. Хаджимба, Иван Викторович Соболев +2
Мақола20182 иқтибос
ABI
STAGE IB2–IIIB CERVICAL CANCER: NEOADJUVANT CHEMOTHERAPY, RADICAL SURGERY AND PATIENT SURVIVAL
Dmitry L. Ovodenko, Grigory N. Khabas, Yu. M. Kreinina +3
Мақола20212 иқтибос
ABI